Real-world long-term outcomes in individuals at clinical risk for psychosis: The case for extending duration of care.
Paolo Fusar-Poli, Andrea De Micheli, Lorenzo Signorini...
https://pubmed.ncbi.nlm.nih.gov/33294806/Actively Recruiting
Led by Centre for Addiction and Mental Health · Updated on 2026-09-09
60
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating a digital dialectical behavior therapy d-DBT intervention designed for youth aged 14 to 35 who are at clinical high risk CHR for psychosis. This study aims to explore the acceptability and feasibility of delivering d-DBT digitally to this population and to assess its potential to improve emotional regulation, reduce psychiatric symptoms, and enhance overall functioning. The trial is an exploratory multi-methods study that will inform future larger-scale clinical trials and clinical applications. Participants will be randomly assigned to receive either the d-DBT intervention or treatment as usual for eight weeks. The d-DBT is a self-directed online program featuring interactive exercises and skill-building modules focused on mindfulness, emotional regulation, distress tolerance, and interpersonal effectiveness. Weekly digital navigator check-ins support participants. Those in the control group continue with standard outpatient care, including routine healthcare visits and any prescribed medications. During the study, participants will undergo assessments at the start and end of the eight-week period, including psychiatric symptom interviews, mood and anxiety scales, substance use questionnaires, and functioning measures. Researchers will track recruitment, retention, adherence, client satisfaction, and system usability throughout the study. The study spans from April 2026 to January 2028, with final evaluations and data collection occurring at eight weeks after intervention start.
CONDITIONS
Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis
M
M. Omair Husain, MBBS, MRCPsych
T
Thea Hedemann, MD, FRCPC
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Centre for Addiction and Mental Health
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 8 weeks
Participants receive either the digital dialectical behavior therapy (d-DBT) intervention or continue with their usual treatment without the digital program for 8 weeks.
Weekly digital navigator check-ins
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Paolo Fusar-Poli, Andrea De Micheli, Lorenzo Signorini...
https://pubmed.ncbi.nlm.nih.gov/33294806/Tandy J Miller, Thomas H McGlashan, Joanna L Rosen...
https://pubmed.ncbi.nlm.nih.gov/14989408/Sean M Robinson, Linda Carter Sobell, Mark B Sobell...
https://pubmed.ncbi.nlm.nih.gov/23276315/Andrada D Neacsiu, Jeremy W Eberle, Rachel Kramer...
https://pubmed.ncbi.nlm.nih.gov/24974307/Kathryn M Connor, Jonathan R T Davidson
https://pubmed.ncbi.nlm.nih.gov/12964174/Simon J Adamson, Frances J Kay-Lambkin, Amanda L Baker...
https://pubmed.ncbi.nlm.nih.gov/20347232/Jean Addington, Mark van der Gaag
https://pubmed.ncbi.nlm.nih.gov/25316912/Kelly Posner, Gregory K Brown, Barbara Stanley...
https://pubmed.ncbi.nlm.nih.gov/22193671/Marsha M Linehan, Kathryn E Korslund, Melanie S Harned...
https://pubmed.ncbi.nlm.nih.gov/25806661/C C Attkisson, R Zwick
https://pubmed.ncbi.nlm.nih.gov/10259963/Centre for Addiction and Mental Health
Lead Sponsor